<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 267 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page266.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=267">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 267 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 267</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=267"><img src="../thumb/267.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>230 / 2020-04                                                            Anti-Microbials - 18.1.2
   Warnings and special precautions: GI dis.hist. esp.ulcerat.colit./  John. syndr., TEN, interstit.nephrit., thrombophlebit. Unknown:   fts.& childr.(15 days - 12 yrs): 20-80 mg/kg bm once dly. Adult dos.
   reg.enterit/pseudomembr.colit., ren.funct.impairm., porphyr., inves-  agranulocytos., pancytopen., trans.incr.in hepat.enzyme lev.& ser.  applic.to childr.with bm.of 50 kg and over. IV doses of &gt; 50 mg/kg bm
   tig.for poss. pseudomembr.colit.if suspect., poss.penicill.& cepha-  bilirub., hepat.dysfunct.incl.cholestas.  admin.as infus.over at least 30 mins.
   lospor. cross.sens., overgrowth of non-suscept. organ.with prolong.  Warnings and special precautions: Penicill./ cephalospor.&   Bact.meningit: Neonates, infts.& childr: Init. 100 mg/kg (not to
   use, Jarish-Herxheim. react. report.follow.Lyme dis.treatm., sucrose   other meds.cross sens., GI dis.hist. esp.ulc.colit./region.enterit./pseu-  exceed 4 g) once dly. Adapt dos.accord.once organism.& sensitiv.est.
   intol., diabet, phenylketonuria, mild laxat.eff.of mannit., safety in   domembr.colit., hepat./ren.funct.impairm., poor nutrit.state, safety   Adults: Recomm.4 g once dly.
   pregn.& lactat.not est., no exper. in childr.und.3 mnths., posit.anti-  in porphyr.not est., discont.immed.& instit.appropr. treatm. if pseu-  Gonorrh: 125 mg IM as sngl.dose.
   globul.( Coombs) test        domembr.colit.susp., superinfect., safety & effic.in childr.3 mnths.&   Periop.infect.prophylax: Sngl.dos.of 1-2 g 30-90  mins.prior to surg.
   Drug interactions: Probenecid incr.AUC, enhanc. nephrotox.with   bel.not est., admin. with other meds., avoid concom. furosemide,   Contraindications: Hypersens., penicill.cross-sens., safety in
   furosemide, poss.nephrotox.with comcom. aminoglycos., OC ef-  safety in pregn.& lactat.not est.  pregn.& lactat.not est.
   fic.poss.reduc.              Interactions: Poss.nephrotoxic.with furosemide & aminoglycosid.,   Side effects: GI disturbs., precipitat.of Ca salts in gallbladd., incr.liv.
                                diuret.aff.ren.funct., reduc.ren. clear. with probenecid.  enzym., pseudomembr.colit., bld. dyscras., prolong.prothromb.time,
   DYNA CEFPODOXIME, Pharma Dynamics [P/S]                    agranulocytos., skin & sev.cutan.advers.reacts.incl.erythema multi-
   Cefpodoxime proxetil equiv.to cefpodoxime.  FORTUM, Sekpharma [P/S]  forme/ Stev.-Johns./Lyell’s syndr./tox. epiderm. necros., headache,
   Indications: Childr: Ac.otit.med., tonsilit., pharyngit., pneum.  Ceftazidime pentahydrate equiv.to ceftazidime.  dizz., oligur., genit. mycos., hypersens.reacts.incl.anaphylact.shock/
   (S4) SUSP, 43/20.1.1/1084    Indications: Sev.infect.incl.septicaem., bacteraem., peritonit.& in   anaphylactoid reacts., loc.reacts., fev., shiver., superinfect., shadows
   716658-001: 40 mg/5 ml, 50 ml, R83,35  immuno-compromis. pts., RTI incl.lung infects.in cyst.fibros., UTI,   detect.by gallbladd. sonogram mistak.for gallston.usual.follow.high.
   716658-002: 40 mg/5 ml, 100 ml, R166,81  ENT, skin & soft tiss., GI, bil.& abdom.infect.  than recomm.dos., pancreatit.
   Dosage: Aveg.dos.8 mg/kg/day 12 hrly.with meals.  (S4) INJ, R/20.1.1/302, 303, 304.  Special precautions: Cross.placenta barr.& excret. in breast milk,
   Childr.betw.10 & 15 kg: 5 ml. 15 kg or more: 10 ml.  727148-001: 500 mg, 1, R75,92  sev.ren.fail., not compat. with sols.contain.Ca & vancomycin/flucona-
   (S4) TABS, 44/20.1.1/0012    727156-004: 1 g, 1, R169,87   zole & aminoglycos., no dos.reduct.reqd.in hepat impairm. provid.ren.
   Indications: Adults: Ac.bronchit.,ac.exacerbat.of chron.bronchit.,   727172-018: 2 g, 1, R343,80  funct.intact., not recomm.in neonates esp. prems.at risk of develop.
   pharyngit., tonsillit., commun. acquir. bronchopneumon., ac.sinusit.  Dosage: IV/IM use. Depend on sev.& sens.of infect., age, mass &   bilirubin encephalopathy.
   716657-001: 100 mg, 10, R94,88  ren.funct. Elderly: Dly.dos.norm.not to exceed 3 g esp. over 80 yrs.
   Dosage: Tonsillit./pharyngit.& ac.bronchit: 1 tab. 12 hrly.  Majority of infects: 1 g 8 hrly or 2 g 12 hrly. Adults: 1-6 g dly. Chil-  KLAFOTAXIM, Ranbaxy [P/S]
   Ac.sinusit./ac.exacerbat.of chron.bronchit./ pneumon:   dr.over 2 mnths.-und.1 yr: 25-50 mg/kg 2xdly. Over 2 mnths: 30-  Cefotaxime sod.equiv.to cefotaxime
   2 tabs 12 hrly               100 mg/ kg/day in 2-3 div. doses. Neonat.& childr.up to 2 mnths:   Indications: Genito-urin., GI, resp.tract, skin & soft tiss.suscept.
   Contraindications: Penicill./other beta-lact. hypersens., childr.und.1   Clin.exper.limit. Dos.of 60 mg/kg/day giv.in 2 div.dos.has prov. effect.  organ.infects., meningit.in childr., prophylact.in potent.contamin.
   yr., safety in pregn.& lactat.not est. Tabs: lact intol.  Immunocompromis./fibrocyst.childr: up to 50 mg/kg 3xdly   surg.proced.
   Side effects: GI disturbs.,oral/vag.candidias., headache, dizzin.,   to max.6 g dly.  (S4) INJ. 31/20.1.1/0328, 0329.
   paraesthes., asthen., seiz., tinnit., hear.loss, hypersens./anaphylact.  Fibrocyst.adults with pseudomon.lung infect: High dose of 100-  870749-005: 500 mg, 1x10 ml vial, R20,52
   reacts., prurit., skin rash, urticar., tox.epiderm.necrolys., erythema mul-  150 mg/kg/day in 3 div.doses. 9 g/day has been used.  871338-009: 1 g, 1x10 ml vial, R19,27
   tiforme, Stev.-Johns.syndr., cutan. erupt., purpura & bullous erupt.,   Contra-indications: Incompat.with vancomycin, mix.with amino-  Dosage: Admin.IM/IV. IV infus.over 20 -60 mins.
   ren.dysfunct., tox. nephropathy, bld.dyscras., hepat.dysfunct.incl.   glycosid.in syr./infus., safety in pregn.not est.  Prophylax: Admin.1 g 30-90 mins.bef.surg. Therap: Adults: Usual.2
   cholestas., elev.liv.enzym., angioed., bronchosp., malaise.  Side-effects: Phleb., pain, inflamm., skin reacts. incl.erythema mul-  g dly.in 2 x 1g dos. Sev: 3-4 g dly in 2-4 dos. Neonates & prems:
   Special precautions: Penicill.& ß-lactam antibiot. cross.sensitiv.,   tiforme/Stev.Johns.syndr./tox. epiderm. necrolys., fev., angioed., an-  Recomm. dos: 0-1 wks: 50 mg/kg IV 12 hrly. 1-4  wks: 50 mg/kg IV
   potent.nephrotox.meds. admin.concom., ren.impairm., poss.de-  aphylax., GI-disturbs., poss.pseudomembr.colit.develop., candidos.,   8 hrly.Infts.& childr: Usual dly. dos: 50-100  mg/kg bm in 2-4 div.dos.
   velolpm.of pseudomembran.colit., susp.cont.aspartame.  vaginit., CNS eff., headache, dizzin., paraesthes., trem., myoclon.,   In except. cas. up to 200  mg/kg/day may be giv.
   Drug interactions: Probenecid incr.ser.lev., absorpt. decr.by ant-  convuls., bld.dyscras.  Contraindications: Safety in pregn.not est.
   acids/histamine H2-recept. antagon., poss.enhanc.nephrotoxic.  Special precautions: Imp.ren.funct., penicill. cross-sens., hyper-  Side effects: Hypersens.reacts.incl.interstit. nephrit. & anaphylax.,
   with loop diuret.            sens.hist., concurr.high dos.with nephrotox.drug treatm., excret.in   bld.dyscras., bleed. complicat., nephrotoxic., ac.ren.tubul.necros.,
   FIXIME, (Biopharma Div) Merck [P/S]  breast milk, superinfect., bact.resist., reg.pt.eval., concom. chloram-  hepatit., cholestat.jaund., convuls., CNS toxic., GI effs., super-infect.
                                phenicol, less stab.in sod.bicarb.
                                                              with prolong.use, loc.reacts., pseudomembran.colit., thrombophlebit.
   Cefixime                                                   Special precautions: Concom.nephrotox.meds. e.g.aminoglycosid.,
   Indications: U&LRT & UT infects.caus.by suscept. organ., un-  FRESENIUS CEFTAZIDIME, Fresenius Kabi [P/S]  elderly, discont.if S&S of pseudomembr.colit.develop, penicill.cross-
   complicat.gonorrh.           Ceftazidime                   sens., allerg. hist., ren.impairm., monit.ren.& haemotol. status dur.
   (S4) TABS, W/20.1.1/256      Indications: Sev.infect.incl.septicaem./bacteraem./peritonit.& in   prolong./high dos.treatm.
   715656-001: 400 mg, 1, R34,19  immunocompromis. pts., RTI, ENT, UTI, skin & soft tiss., GI, bil.&   Drug interactions: Incr.ren.damage risk with gentamicin, enhanc.
   715656-002: 400 mg, 5, R171,96  abdom.infect.              nephrotoxic.with loop diurets., probenecid inhibit.ren.excret., antago-
   Dosage: Ther.durat.:5-14 days.  (S4) POWD.FOR SOL.FOR INJ, 43/20.1.1/0554, 0555  nist.act.with bacteriostat. antibact.agents.
   Adults & childr.over 12 yrs: Recomm.dos: 200-400 mg dly.as sngl.  720009-001: 1 000 mg, 10x10 ml, R802,26
   dos.or 2 div.dos.            720010-001: 2 000 mg, 10x50 ml, R1 518,00  LITHA CEFAZOLIN, Litha [P/S]
   LRTI: 400 mg dly.            Dosage: Admin.IV/deep IM. Dos.depend.on sev., sens.& infect.type &   Cefazolin sodium equiv.to cefazolin.
   URTI: 200 mg once dly. In sinusit.admin.x10-14 days.  pt.age, mass, ren.funct. Adults: 1-6 g/dly.in div.dos.every 8 to 12 hrs.  Indications: Suscept.organ.resp. tract, GUT, skin & soft tiss., bone
   Uncomplic.UTI: 200 mg once dly.  UTI & less ser.infects: 500 mg or 1 g 12 hrly usual.adeq.   & joint infects., endocardit., pre-operat./intra-operat. & post-op.
   Uncomplic.gonorrh: 400 mg sngl.oral dos.  Very sev.infect. esp.immunocompromis. pts.incl. those with   prophylax.in abdom.hysterect.
   Contraindications: Safety & effic.in neonates incl.preterm neonates   neutropen: Admin. 2 g 8-12 hrly.   (S4)POWD.FOR INJ, 31/20.1.1/0352, 0353
   not est., safety in pregn.& lactat.not est.  Cystic fibros.with pseudomon.lung infect: 100-150 mg/kg/day   701885-004: 500 mg, 10 vials, R135,26
   Side effects: Superinfect., hypersens.reacts.incl. anaphylax.& ser.  in 3 div.dos. 9 g/day has been used in adults.  701884-003: 1 g, 10 vials, R149,21
   sickn.-like reacts., skin & subcutan. tiss.disords.incl.tox.epiderm.  Infts & childr.&gt; 2 mnths: Usual dos: 30-100 mg/ kg dly.in 2-3 div.dos.   Dosage: IV/IM admin/IV infus.
   necrolys./ Stev. Johns.syndr.& erythema exudat.multiforme, head-  Childr.&gt; 2 mnths.but und. 1 yr: Usual.25-50 mg/kg 2x dly. Infect.   Adults: 250 mg-1 g 6-8-12 hrly. Sev.infect: up to 6 g/day.
   ache, dizzin., trans.hyperactiv., GI disturbs., bld. dyscras., coagu-  immunocompromis./fibrocyst.childr: Dos.up to 50 mg/kg 3x dly.  Childr: 25-50 mg/kg bm/day in 3-4 div.dos. May be incr.to 100 mg/
   lat.disords., revers.hepat. enzyme elev., hepatit., cholestat.jaund.  to max.6 g dly may be giv.  kg bm/day in sev.infects.
   Special precautions: Not suitable for staphylococc. infects.as   Neonates & childr.up to 2 mnths: 60 mg/kg dly.giv. in 2 div.dos.  Peri-op.prophylax: 1 g IV/IM ½-1 hr.prior to surg. For proced.2 hrs.
   they are resist., other cephalospor.hypersens., poss.penicillin cross-  Elderly: Gen.not exceed.3 g dly.  or long.1 g IV/IM dur. proced. (modify admin.accord.to proced.durat.)
   sens., asthma, allerg.diathes., imp.ren.funct., poss. antibiot.assoc.  Contraindications: Safety in pregn.& lactat.not est., incompat.  then 1 g IV/IM 6-8 hrly.postop x24 hrs.max.
   pseudomembr.colit., sev.exist.GI disturbs., concom.diuret./potent.  with vancomycin.  Contraindications: Safety in pregn./lactat.& use in prems.& infts.
   nephrotox.meds. esp.with underly.condits.where ren.ischaem.poss.  Side effects: Candidos., vaginit., bld.dyscras., bleed. complic.relat.  und.1 mnth.not est., porphyr.
   Drug interactions: Nephrotox.meds.incr.ren. impairm.risk, nifedi-  to thrombocytopen.&/platel. dysfunct., GI disturbs., superinfect., incr.  Side effects: Hypersens.reacts.incl.anaphylax., bld. dyscras., bleed.
   pine incr.bioavailabil., platelet aggregat.inhibit.may incr.haemorrh.  liv. enzym., hepatit., cholestat.jaund., hypersens.incl. skin reacts./  complicat.relat.to platelet dysfunct/ hypoprothrombinaem., ac.ren.
   risk assoc.with salicylates/cephalospor./NSAID’s & sulfinpyrazone,   fev./ser.sickn./ac.interstit.nephrit.& anaphylax., headache, dizzin.,   tubul. necros. & convuls./CNS toxic.follow.excess.dos./in pre-exist.
   probenecid incr.ser.conc.    paraesthes., bad taste, convuls., CNS toxic., Stev.John.syndr., ery-  ren.impairm., hepatit.& cholestat.jaund., GI disturbs., superinfect.,
                                thema multiforme, nephrotoxic., inj.site reacts., thrombophlebit./  pseudomembr.colit., loc. reacts.
   FKSA CEFUROXIME, Fresenius Kabi [P/S]  phlebit.aft.infus.  Special precautions: Penicill.cross-sens., prev. drug allerg., ren.
   Cefuroxime as cefuroxime sod.  Warnings and special precautions: Penicill. sens., known hist.of   impairm., concom.nephrotox. meds. eg.aminoglycos..incr.poss
   Indications: Suscept.RTI, ENT, UTI, soft tiss., gynae./obstet.infects.,   allerg., excret.in breast milk, poss. pseudomembr.colit., imp.ren.funct.,   kidn.damage risk.
   gonorrh., prophylax.bef. surg.where incr.infect.risk. Admin.concom.   monit. ren./ haematolog.stat.dur.prolong.& high dos. ther., elderly.  Drug interactions:.Loop diuret.enhanc. nephrotox., probenecid
   aminoglycosid.with Pseudomonas aeruginosa infects  Drug interactions: Enhanc.nephrotoxic.with loop diurets. e.g.   inhibit.ren.excret., poss. antagon. with bacteriostat.antibact.agents.
   (S4) INJ, 42/20.1.1/0737, 0986  furosemide, incr.kidn.damage risk with concom. nephrotox.meds.,
   718555-001: 750 mg, 10x15 ml vial, R178,25  probenecid inhibits.ren. excret., poss.antagon.with bacteriostat.anti-  LITHA CEFOTAXIME, Litha [P/S]
   779245-008: 1 500 mg, 10x20 ml vial, R356,50  bact./ chloramphenicol.  Cefotaxime.sod.equiv.to cefotaxime base
   Dosage: Adults: 750 mg 3xdly, IM/IV.                       Indications: Suscept.organ.infects.of genito-urin. / GI & resp.
   Sev.infects: 1,5 g 3xdly IV, freq.may be incr.to 6 hrly if necess.  FRESENIUS CEFTRIAXONE Fresenius Kabi [P/S]  tract, skin & soft tiss., meningit.in childr., prophylact.in potent.con-
   Infts.&gt; 3 mnths. & childr: 30-60 mg/kg/day incr.to 100 mg/kg/day if   Ceftriaxone.  tamin.surg.proced.
   necess.giv.in 3-4 div.dos. 60 mg/kg/day usual.appropr.for most infects.  Indications: Bact.septicaem., meningit., intra-abdom.infects., skin &   (S4) INJ. 34/20.1.1/0047,0048
   Gonorrh: 1,5 g as sngl.dos. May be giv.as 2x 750 mg inj.into dif-  skin struct./bones & joint/ ren.& urin.tract/resp.tract & ENT infects.  889203-001: 500 mg, sngl.vials, R13,05
   fer.sites.                   caus.by suscept.organ., uncomplic.gonorrh., peri-op.infect. prophylax.  889199-001: 1 g, sngl.vials, R22,19
   Prophylax., abdom.& gynae.ops: 1,5 g IV with anaesthes.induct.,   (S4) INJ. 38/20.1.1/0078, 0077, 0076; 0075  Dosage: Admin.concom.aminoglycoside.with Infects.caus.by Pseu-
   then 2x750 mg IM 8 & 16 hrs. later.  707948-001: 250 mg, 10 vials, R272,86  domonas aeruginosa. Do not mix with other antibiot.in syr./infus.
   Card.& pulm.ops: 1,5 g with anaesthes.induct. then 750 mg IM   707949-001: 500 mg, 10 vials, R443,43  Adults: Usual.2 g dly in 2 dos. Sev: 3-4 g dly in 2-4 dos. Neonates:
   3xdly x24-48 hrs.            707950-001: 1 g, 10 vials, R478,00  0-1 wk: 50 mg/kg IV 12 hrly. 1-4 wks: 50 mg/kg IV 8 hrly. Childr:
   Contraindications: Penicill./other β-lact. hypersens.  707951-001: 2 g, 1x30 ml vial, R50,75  Usual dly dos. 50 -100 mg/kg bm in 2-4 inj.& in except.cases up
   Side effects: Freq: Eosinophil., headache. Less freq: leucopen.,   707964-001: 2 g, 1x50 ml vial, R84,79  200 mg/kg/day may be giv.
   thrombocytopen., neutropen., hypoprotrombinaem., haemolyt.  Dosage: Admin.IM/IV.  Prophylax: 1 g 30-90 mins.pre-op.
   anaem., hypersens. reacts.incl.skin rashes, uritcar., prurit., bronchosp.,   Adults & childr.over 12 yrs: 1-2 g dly. Max: 4 g dly.  Contraindications: Safety in pregn.& lactat.not est.
   drug fev., ser.sickn., anaphylax., angioed., seiz., mild to mod.hear.loss,   Neonates up to 14 days (not necess.to different. betw.prem.& term   Side effects: Skin reacts., anaphylax., GI disturbs., bld.dyscras.,
   N&V, abdom.pain, diarrh. poss.with bld., erythem.multiform., Stev.-  infts) 20-50 mg/kg bm once dly. Dly.dos.not to exceed 50 mg/kg. In-  fev., deep phlebit.aft.IV inj., bleed. complicat. relat.to hypoprothrom-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page266.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page262.html">262</a>&nbsp;&nbsp;&nbsp;<a href="page263.html">263</a>&nbsp;&nbsp;&nbsp;<a href="page264.html">264</a>&nbsp;&nbsp;&nbsp;<a href="page265.html">265</a>&nbsp;&nbsp;&nbsp;<a href="page266.html">266</a>&nbsp;&nbsp;&nbsp;<a href="page267.html">267</a>&nbsp;&nbsp;&nbsp;<a href="page268.html">268</a>&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>&nbsp;&nbsp;&nbsp;<a href="page272.html">272</a>
             </td>
             <td width="35%"><a href="page268.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page268.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
